Ambit Biosciences Corp (NASDAQ:AMBI)

--
Delayed Data
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date
No recent news for Ambit Biosciences Corp.

Today’s Trading

Previous close--
Today’s open--
Day’s range-- - --
Volume--
Average volume (3 months)--
Market cap--
Dividend yield--
Data as of --

Growth & Valuation

Earnings growth (last year)+80.86%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+53.65%
P/E ratio--
Price/Sales3.92
Price/Book4.85

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV+3.47+42.06%
NHTCNatural Health Trend...+0.05+0.22%
AGRXAgile Therapeutics I...+0.33+2.65%
SVASinovac Biotech Ltd0.000.00%
Data as of 4:00pm ET, 04/24/2015

Financials

Last reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$27.1M
Annual profit (last year)-$13.1M
Net profit margin-48.29%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Michael A. Martino
Senior Vice President &
General Counsel
Annette North
Corporate headquarters
San Diego, California

Forecasts

Chart unavailable

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers